Request Trial
jackie-7
26 November 2020

Five minutes with… Jacqueline Mulryne

Amid the unprecedented challenges presented by COVID-19, questions around the use of second medical use (SMU) patents have become increasingly pertinent. On Tuesday December 1, LSPN Connect ’s session: Addressing Second Medical Use Infringement: An Evaluation of Recent SMU Cases will examine a number of key issues relating to this pivotal area of life sciences IP.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

MedTech
HeartFlow targets AI cardiac imaging rival over patents and trade secrets
27 October 2026   The 179-page lawsuit alleges that a Boston-based company used patented technology and confidential information from former employees to develop a competing cardiac imaging product.
Careers
Womble Bond Dickinson loses trio of partners to US rival
27 October 2026   The departing partners bring expertise across molecular biology, biochemistry, small molecule and peptide drugs, including blockbuster therapies, as well as chemical and mechanical technologies.
In-house counsel
‘Companies that don’t leverage AI will struggle to keep up’: Umicore IP chief
26 October 2026   Umicore’s Sean Alexander has seen the profession change considerably over three decades, but some of its biggest changes may still lie ahead. He tells LSIPR why AI is prompting difficult decisions, what he is no longer willing to pay external counsel for and why Europe is the place to watch.


Editor's picks

WATCH: Medmix global IP head on building business-focused IP teams
In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026

Editor's picks

In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026
MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026
Pharma
Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom
6 October 2026
In-house counsel
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
1 October 2026
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
1 October 2026
Pharma
Takeda sees off UK challenge to Elvanse SPC
28 September 2026

More features

HeartFlow targets AI cardiac imaging rival over patents and trade secrets
Womble Bond Dickinson loses trio of partners to US rival
‘Companies that don’t leverage AI will struggle to keep up’: Umicore IP chief
Mewburn Ellis hires first CTO to boost investment in AI and digital innovation
10x and Parse set to end sequencing feud after appeals court defeat
Dr Reddy’s eyes appeal stakes as Boehringer hearing ends
Amarin and Hikma call time on six-year skinny label fight
WATCH: Medmix global IP head on building business-focused IP teams